AGIOS PHARMACEUTICALS, INC. ($AGIO)
Gheuens Sarah โ Chief Medical Officer
Shares
7,866
Price
$0.00
Total Value
$0.00
Nearby Earnings
Oct 29, 2026
EPS:Est: -1.24
Revenue:Est: $53.36M
Nov 5, 2026 ๐
EPS:-1.09 (est: -1.24)-12.1%
Revenue:$55.38M (est: $51.65M)+7.2%
Transaction Details
| Insider | Gheuens Sarah |
|---|---|
| Title | Chief Medical Officer |
| Transaction Date | Oct 26, 2026 |
| Expiration Date | Mar 1, 2033 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock options (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Oct 28, 2026 |
| Shares Purchased | 7,866 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 16,275 |
| Derivative | Derivative |
| Accession Number | 0001439222-26-000124 |
| Document | View SEC Filing |